SkyQuest Technology Group has recently published a comprehensive Organ on Chip Market report, offering a detailed analysis of the product landscape and industry scope while providing insights into the market outlook and future trends from 2025 to 2032. An organ-on-a-chip is a microfluidic cell culture device that contains continuously perfused chambers. This chip develops a narrow channel for the blood and airflow in different organs like lungs, gut, liver, heart, and others. These devices offer a wide range of applications like disease modelling, drug designing and toxicity testing.
Organ on Chip Market size was valued at USD 68.63 Billion in 2023 and is poised to grow from USD 89.74 Billion in 2024 to USD 587.01 Billion by 2032, growing at a CAGR of 30.76% during the forecast period (2025-2032).
The global organ on chip market can be describe by rapid technological advancements, growing adoption across pharma, biotech and academic sectors as well as increasing fundings and investments in research and developments. For instance, in December 2021, Emulate, Inc., stated that its Brain Chip was sent to the ISS National Lab to study the effects of microgravity on human brain physiology as part of the tissue-chips in space initiative sponsored by the NCATS at NIH and the ISS-NL.
Get a Free Sample PDF of the Report – https://www.skyquestt.com/sample-request/organ-on-chip-market
Detailed Segmentation and Classification of the report (Market Size and Forecast – 2032, Y-o-Y growth rate, and CAGR):
The Organ on Chip Market can be segmented based on several factors, including product type, application, end-user, and distribution channel.
Global Organ On Chip Market is segmented by organ type, model type, product, purpose, application, end user and region.
Based on organ type, the market is segmented into liver, kidney, intestine, lung, heart and other organs.
Based on model type, the market is segmented into organ-based models and disease-based models.
Based on product, the market is segmented into services and products.
Based on purpose, the market is segmented into therapeutics and research.
Based on application, the market is segmented into toxicology research, drug discovery, physiological model development, tissue regeneration & regenerative medicine and stem cell research.
Based on end user, the market is segmented into pharmaceutical and biotechnology companies, cosmetics industry, academic & research institutes and other end users.
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Organ on Chip Market – Regional Analysis:
North America has traditionally been the largest market for the organ-on-chip technology. It is leading region in the adoption of this tech due to presence of various pharma companies, research institutions and tech developers. This region has a robust environment for biotech and life science which caters to new innovations. Regulatory agencies like FDA engage with the stakeholders to explore the potential use in drug discovery and safety assessments.
However, the Asia-Pacific region has been experiencing a rapid growth in the organ-on-chip market. Specially countries like Japan, China, South Korea and Singapore have been making substantial investments in research and new innovations. The rising demand for personalised medicines and development in healthcare infrastructure as well as presence of large pharmaceutical market further makes it the fastest growing market.
Top Market Players in Organ on Chip Market are:
Emulate, Inc.
Mimetas B.V.
Tissuse GmbH
CN Bio Innovations Ltd.
InSphero
Alveolix AG
Fluigent
Nortis, Inc.
Hesperos, Inc.
AxoSim
BEOnChip
Altis Biosystems
Synvivo, Inc.
Obatala Sciences
Dynamic42 GmbH
Lena Biosciences
AIM Biotech Pte. Ltd.
React4life
Initio Cell
Netri SAS
Recent Developments:
In June 2023, MatTek Life Sciences announced a strategic partnership with AIM Biotech enabling the availability of AIM Biotech portfolio for sale through MatTek.
In June 2023, Dynamic42 raised an undisclosed amount through a Series A funding round to expand internationally.
In June 2023, Emulate launched Emulate Chip-A1 to widen its applications in cancer and cosmetic markets.
You may Also Like
https://issuu.com/skyquest-technology/docs/why_is_the_gaming_chair_market_thriving_in_the_esp/s/90097212
https://issuu.com/skyquest-technology/docs/autogas_market_overview_revenue_segmentation_an
Forward-Looking Insights
The Organ on Chip Market is set to experience sustained growth, fueled by technological advancements, broader global market access, and rising industry demand. With the industry addressing emerging challenges and capitalizing on new opportunities, it is expected to drive innovation and play a pivotal role in advancing global health and economic progress.
About Company:
SkyQuest is an IP focused Research and Investment Bank and Accelerator of Technology and assets. We provide access to technologies, markets and finance across sectors viz. Life Sciences, CleanTech, AgriTech, NanoTech and Information & Communication Technology.
We work closely with innovators, inventors, innovation seekers, entrepreneurs, companies and investors alike in leveraging external sources of R&D. Moreover, we help them in optimizing the economic potential of their intellectual assets. Our experiences with innovation management and commercialization have expanded our reach across North America, Europe, ASEAN and Asia Pacific.
Contact Details:
SkyQuest Technology Group
USA (+1) 351-333-4748
Email: [email protected]
